Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Future Developments in Biosensors for Field-Ready Sars-Cov-2 Virus Diagnostics Publisher Pubmed



Fani M1 ; Zandi M2 ; Soltani S2 ; Abbasi S3
Authors

Source: Biotechnology and Applied Biochemistry Published:2021


Abstract

According to the evidence, the coronavirus disease 19 (COVID-19) is caused by a zoonotic pathogen named respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus can spread through personal contact, respiratory droplets, and also through airborne transmission. A rapid, low-cost, and effective biosensor platform is essential to diagnose patients with COVID-19 infection, predominantly the asymptomatic individuals, and prevent the spread of the SARS-CoV-2 via transmission routes. The objective of this review is to provide a comparative view among current diagnostic methods, focusing on recently suggested biosensors for the detection of SARS-CoV2 in clinical samples. A capable SARS-CoV-2 biosensor can be designed by the holistic insights of various biosensor studies. © 2020 International Union of Biochemistry and Molecular Biology, Inc.
Related Docs
View other Related Docs
1. Simultaneous Detection of Sars-Cov-2 Igg/Igm Antibodies, Using Gold Nanoparticles-Based Lateral Flow Immunoassay, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2021)
2. Hypothesis: Designation of Liposomal Scavenger System for Fight Against 2019-Ncov, Infectious Disorders - Drug Targets (2022)
3. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
Experts (# of related papers)
View all Related Experts
Yousef Erfani (2)
Hossein Khalili (1)
Other Related Docs
4. Evaluation of Common Respiratory Viruses Other Than Sars-Cov-2 in Hospitalized Children During the Covid-19 Pandemic, BMC Infectious Diseases (2025)
5. Evaluating the Efficiency of Elisa, Monoplex and Multiplex Probe-Based Real-Time Reverse-Transcription Pcr Assays in the Detection of Sars-Cov-2 (Covid-19) and Influenza a and B Viruses: A Cross-Sectional Study, Health Science Reports (2024)
6. Clinical Symptoms and Types of Samples Are Critical Factors for the Molecular Diagnosis of Symptomatic Covid-19 Patients: A Systematic Literature Review, International Journal of Microbiology (2021)
7. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
8. Covid-19: Why Does Disease Severity Vary Among Individuals?, Respiratory Medicine (2021)
9. A Comparison Between Sars-Cov-1 and Sars-Cov2: An Update on Current Covid-19 Vaccines, DARU# Journal of Pharmaceutical Sciences (2022)
10. Sars-Cov-2 Detection by Targeting Four Loci of Viral Genome Using Graphene Oxide and Gold Nanoparticle Dna Biosensor, Scientific Reports (2022)
11. Covid-19: Significance of Antibodies, Human Antibodies (2020)
12. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
13. State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2, ACS Applied Materials and Interfaces (2021)
14. Molecular Aspects of Co-Morbidities in Covid-19 Infection, Archives of Bone and Joint Surgery (2020)
15. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
16. The Immunologic Basis of Covid-19: A Clinical Approach, Journal of Cellular and Molecular Anesthesia (2020)
17. Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (Varid), International Journal of Molecular Sciences (2021)
18. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)
19. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
20. Challenges Posed by Covid-19 in Cancer Patients: A Narrative Review, Cancer Medicine (2022)